EX-99.3 4 d730124dex993.htm EX-99.3 EX-99.3

Exhibit 99.3

 

 

LOGO

NUTRIEN LTD.

INTERIM FINANCIAL STATEMENTS AND NOTES

AS AT AND FOR THE THREE MONTHS ENDED

MARCH 31, 2024


Unaudited  

 

Condensed Consolidated Financial Statements

Condensed Consolidated Statements of Earnings

 

            Three Months Ended
March 31
 
 (millions of US dollars, except as otherwise noted)    Note      2024      2023  

 SALES

     2, 9        5,389        6,107  

 Freight, transportation and distribution

        238        199  

 Cost of goods sold

              3,614        3,995  

 GROSS MARGIN

        1,537        1,913  

 Selling expenses

        794        770  

 General and administrative expenses

        154        145  

 Provincial mining taxes

        68        119  

 Share-based compensation expense

        6        15  

 Other expenses (income)

     3        96        (75

EARNINGS BEFORE FINANCE COSTS AND INCOME TAXES

 

     419        939  

 Finance costs

              179        170  

EARNINGS BEFORE INCOME TAXES

        240        769  

 Income tax expense

     4        75        193  

NET EARNINGS

              165        576  

 Attributable to

        

 Equity holders of Nutrien

        158        571  

 Non-controlling interest

              7        5  

NET EARNINGS

              165        576  

NET EARNINGS PER SHARE ATTRIBUTABLE TO EQUITY HOLDERS OF NUTRIEN (“EPS”)

 

 Basic

        0.32        1.14  

 Diluted

              0.32        1.14  

 Weighted average shares outstanding for basic EPS

        494,570,000        501,175,000  

 Weighted average shares outstanding for diluted EPS

              494,792,000        502,220,000  
Condensed Consolidated Statements of Comprehensive Income

 

            Three Months Ended
March 31
 
 (millions of US dollars)            2024      2023  

NET EARNINGS

        165        576  

 Other comprehensive (loss) income

        

 Items that will not be reclassified to net earnings:

        

 Net actuarial loss on defined benefit plans

        -        (3

 Net fair value (loss) gain on investments

        (18      5  

 Items that have been or may be subsequently reclassified to net earnings:

        

 (Loss) gain on currency translation of foreign operations

        (66      1  

 Other

              (18      (1

OTHER COMPREHENSIVE (LOSS) INCOME

              (102      2  

COMPREHENSIVE INCOME

              63        578  

 Attributable to

        

 Equity holders of Nutrien

        57        573  

 Non-controlling interest

              6        5  

COMPREHENSIVE INCOME

              63        578  

 (See Notes to the Condensed Consolidated Financial Statements)

 

22


Unaudited  

 

Condensed Consolidated Statements of Cash Flows

 

            Three Months Ended
March 31
 
 (millions of US dollars)    Note      2024      2023  
                   Note 1  

OPERATING ACTIVITIES

        

 Net earnings

        165        576  

 Adjustments for:

        

 Depreciation and amortization

        565        496  

 Share-based compensation expense

        6        15  

 Provision for deferred income tax

        28        21  

 Net (undistributed) distributed earnings of equity-accounted investees

        (50      163  

 Gain on amendments to other post-retirement pension plans

     3        -        (80

 Loss on Blue Chip Swaps

     3        19        -  

 Long-term income tax receivables and payables

        43        (72

 Other long-term assets, liabilities and miscellaneous

              64        7  

 Cash from operations before working capital changes

        840           1,126  

 Changes in non-cash operating working capital:

        

 Receivables

        (257      535  

 Inventories and prepaid expenses and other current assets

        (1,330      (1,493

 Payables and accrued charges

              260        (1,026

CASH USED IN OPERATING ACTIVITIES

              (487      (858

 INVESTING ACTIVITIES

        

 Capital expenditures 1

        (373      (465

 Business acquisitions, net of cash acquired

        -        (111

 Proceeds from sales of Blue Chip Swaps, net of purchases

     3        (19      -  

 Net changes in non-cash working capital

        (90      (100

 Other

              (12      (18

CASH USED IN INVESTING ACTIVITIES

              (494      (694

 FINANCING ACTIVITIES

        

 Proceeds from debt with maturity periods within three months, net

        926        1,873  

 Proceeds from debt

        -        1,500  

 Repayment of debt

        (14      (17

 Repayment of principal portion of lease liabilities

        (96      (87

 Dividends paid to Nutrien’s shareholders

        (261      (246

 Repurchase of common shares

        -        (897

 Issuance of common shares

        1        28  

 Other

              (8      (25

CASH PROVIDED BY FINANCING ACTIVITIES

              548        2,129  

 EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS

              (12      (5

 (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

        (445      572  

 CASH AND CASH EQUIVALENTS – BEGINNING OF PERIOD

              941        901  

 CASH AND CASH EQUIVALENTS – END OF PERIOD

              496        1,473  

 Cash and cash equivalents is composed of:

        

 Cash

                422                361  

 Short-term investments

              74        1,112  
                   496        1,473  

 SUPPLEMENTAL CASH FLOWS INFORMATION

        

 Interest paid

        132        98  

 Income taxes paid

        50        1,319  

 Total cash outflow for leases

              131        119  

 1 Includes additions to property, plant and equipment, and intangible assets for the three months ended March 31, 2024 of $338 million and $35 million (2023 – $422 million and $43 million).

 (See Notes to the Condensed Consolidated Financial Statements)

 

23


Unaudited  

Condensed Consolidated Statements of Changes in Shareholders’ Equity

 

                      Accumulated Other Comprehensive
(Loss) Income (“AOCI”)
                         
 (millions of US dollars, except as
otherwise noted)
  Number of
Common
Shares
    Share
Capital
    Contributed
Surplus
    (Loss) Gain
on Currency
Translation
of Foreign
Operations
    Other    

Total

AOCI

    Retained
Earnings
    Equity
Holders
of
Nutrien
    Non-
Controlling
Interest
    Total
Equity
 
           

 BALANCE – DECEMBER 31, 2022

    507,246,105       14,172       109       (374     (17     (391     11,928       25,818       45       25,863  
           

 Net earnings

    -       -       -       -       -       -       571       571       5       576  
           

 Other comprehensive income

    -       -       -       1       1       2       -       2       -       2  
           

 Shares repurchased

    (11,751,290     (328     -       -       -       -       (571     (899     -       (899
           

 Dividends declared - $0.53/share

    -       -       -       -       -       -       (265     (265     -       (265
           

 Non-controlling interest transactions

    -       -       -       -       -       -       -       -       (6     (6

 Effect of share-based compensation including issuance of common shares

    579,208       34       (3     -       -       -       -       31       -       31  

 Transfer of net loss on cash flow hedges

    -       -       -       -       5       5       -       5       -       5  

 Transfer of net actuarial loss on defined benefit plans

    -       -       -       -       3       3       (3     -       -       -  

 Other

    -       -       -       (2     -       (2     -       (2     -       (2
           

 BALANCE – MARCH 31, 2023

    496,074,023       13,878       106       (375     (8     (383     11,660       25,261       44       25,305  
           

 BALANCE – DECEMBER 31, 2023

    494,551,730       13,838       83       (286     (10     (296     11,531       25,156       45       25,201  
           

 Net earnings

    -       -       -       -       -       -       158       158       7       165  
           

 Other comprehensive loss

    -       -       -       (65     (36     (101     -       (101     (1     (102
           

 Dividends declared - $0.54/share

    -       -       -       -       -       -       (266     (266     -       (266
           

 Non-controlling interest transactions

    -       -       -       -       -       -       -       -       (8     (8
           

 Effect of share-based compensation including issuance of common shares

    37,199       2       2       -       -       -       -       4       -       4  

 Transfer of net loss on cash flow hedges

    -       -       -       -       2       2       -       2       -       2  
         

 BALANCE – MARCH 31, 2024

    494,588,929       13,840       85       (351     (44     (395     11,423       24,953       43       24,996  

 (See Notes to the Condensed Consolidated Financial Statements)

 

24


Unaudited  

 

Condensed Consolidated Balance Sheets

 

          March 31            December 31  
As at (millions of US dollars)    Note        2024          2023              2023  

ASSETS

             

Current assets

             

Cash and cash equivalents

        496        1,473          941  

Receivables

   6, 9      5,561        6,009          5,398  

Inventories

        8,188        9,852          6,336  

Prepaid expenses and other current assets

          905        937          1,495  
        15,150        18,271          14,170  

Non-current assets

             

Property, plant and equipment

        22,410        21,832          22,461  

Goodwill

        12,083        12,433          12,114  

Intangible assets

        2,165        2,292          2,217  

Investments

        768        686          736  

Other assets

          999        1,078          1,051  

TOTAL ASSETS

          53,575        56,592          52,749  

LIABILITIES

             

Current liabilities

             

Short-term debt

   6      2,835        4,013          1,815  

Current portion of long-term debt

        513        545          512  

Current portion of lease liabilities

        346        306          327  

Payables and accrued charges

          9,431        10,611          9,467  
        13,125        15,475          12,121  

Non-current liabilities

             

Long-term debt

        8,910        9,510          8,913  

Lease liabilities

        1,034        880          999  

Deferred income tax liabilities

        3,601        3,603          3,574  

Pension and other post-retirement benefit liabilities

        246        242          252  

Asset retirement obligations and accrued environmental costs

        1,485        1,389          1,489  

Other non-current liabilities

          178        188          200  

TOTAL LIABILITIES

          28,579        31,287          27,548  

SHAREHOLDERS’ EQUITY

             

Share capital

        13,840        13,878          13,838  

Contributed surplus

        85        106          83  

Accumulated other comprehensive loss

        (395      (383        (296

Retained earnings

          11,423        11,660          11,531  

Equity holders of Nutrien

        24,953        25,261          25,156  

Non-controlling interest

          43        44          45  

TOTAL SHAREHOLDERS’ EQUITY

          24,996        25,305          25,201  

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

          53,575        56,592          52,749  

(See Notes to the Condensed Consolidated Financial Statements)

 

25


Unaudited  

 

Notes to the Condensed Consolidated Financial Statements

As at and for the Three Months Ended March 31, 2024

Note 1 Basis of presentation

Nutrien Ltd. (collectively with its subsidiaries, “Nutrien”, “we”, “us”, “our” or “the Company”) is a leading provider of crop inputs and services. Nutrien plays a critical role in helping growers around the globe increase food production in a sustainable manner.

These unaudited interim condensed consolidated financial statements (“interim financial statements”) are based on International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, “Interim Financial Reporting”. The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2023 annual audited consolidated financial statements, as well as any amended standards adopted in 2024 that we previously disclosed. These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual audited consolidated financial statements and should be read in conjunction with our 2023 annual audited consolidated financial statements. Certain immaterial 2023 figures have been reclassified in the condensed consolidated statements of cash flows.

In management’s opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year. These interim financial statements were authorized by the Audit Committee of the Board of Directors for issue on May 8, 2024.

Note 2 Segment information

We have four reportable operating segments: Nutrien Ag Solutions (“Retail”), Potash, Nitrogen and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seed and merchandise. Retail provides services directly to growers through a network of farm centers in North America, South America and Australia. The Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each produces.

 

    Three Months Ended March 31, 2024  
(millions of US dollars)   Retail     Potash     Nitrogen     Phosphate      Corporate
and Others
    Eliminations     Consolidated  

 Sales   – third party

    3,308       821       846       414        -       -       5,389  

        – intersegment

    -       106       182       85        -       (373     -  

 Sales   – total

    3,308       927       1,028       499        -       (373     5,389  

 Freight, transportation and distribution 1

    -       114       117       62        -       (55     238  

 Net sales

    3,308       813       911       437        -       (318     5,151  

 Cost of goods sold

    2,561       358       604       372        -       (281     3,614  

 Gross margin

    747       455       307       65        -       (37     1,537  

 Selling expenses

    790       3       7       2        (2     (6     794  

 General and administrative expenses

    52       4       5       4        89       -       154  

 Provincial mining taxes

    -       68       -       -        -       -       68  

 Share-based compensation expense

    -       -       -       -        6       -       6  

 Other expenses (income)

    22       (3     (33     8        97       5       96  

 (Loss) earnings before finance costs and income taxes

    (117     383       328       51        (190     (36     419  

 Depreciation and amortization

    194       147       136       70        18       -       565  

 EBITDA 2

    77       530       464       121        (172     (36     984  

 Share-based compensation expense

    -       -       -       -        6       -       6  

 ARO/ERL expense for non-operating sites 3

    -       -       -       -        3       -       3  

 Foreign exchange loss, net of related derivatives

    -       -       -       -        43       -       43  

 Loss on Blue Chip Swaps

    -       -       -       -        19       -       19  

 Adjusted EBITDA

    77       530       464       121        (101     (36     1,055  

 Assets – as at March 31, 2024

    24,273       13,562       11,606       2,420        2,326       (612     53,575  

 1 Potash freight, transportation and distribution only applies to our North American potash sales volumes.

 2 EBITDA is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

 3 ARO/ERL refers to asset retirement obligations and accrued environmental costs.

 

26


Unaudited  

 

     Three Months Ended March 31, 2023  
 (millions of US dollars)    Retail     Potash     Nitrogen     Phosphate      Corporate
and Others
    Eliminations     Consolidated  

 Sales   – third party

     3,422       1,023       1,154       508        -       -       6,107  

        – intersegment

     -       54       264       64        -       (382     -  

 Sales   – total

     3,422       1,077       1,418       572        -       (382     6,107  

 Freight, transportation and distribution

     -       75       106       58        -       (40     199  

 Net sales

     3,422       1,002       1,312       514        -       (342     5,908  

 Cost of goods sold

     2,807       305       771       427        -       (315     3,995  

 Gross margin

     615       697       541       87        -       (27     1,913  

 Selling expenses

     765       3       8       2        (2     (6     770  

 General and administrative expenses

     50       3       5       3        84       -       145  

 Provincial mining taxes

     -       119       -       -        -       -       119  

 Share-based compensation expense

     -       -       -       -        15       -       15  

 Other expenses (income)

     15       (7     (14     12        (81     -       (75

 (Loss) earnings before finance costs and income taxes

     (215     579       542       70        (16     (21     939  

 Depreciation and amortization

     181       97       134       67        17       -       496  

 EBITDA

     (34     676       676       137        1       (21     1,435  

 Integration and restructuring related costs

     -       -       -       -        5       -       5  

 Share-based compensation expense

     -       -       -       -        15       -       15  

 Foreign exchange gain, net of related derivatives

     -       -       -       -        (34     -       (34

 Adjusted EBITDA

     (34     676       676       137        (13     (21     1,421  

 Assets – as at December 31, 2023

     23,056       13,571       11,466       2,438        2,818       (600     52,749  

 

    Three Months Ended March 31  
(millions of US dollars)     2024       2023  

 Retail sales by product line

   

Crop nutrients

    1,309       1,335  

Crop protection products

    1,114       1,154  

Seed

    485       507  

Services and other

    156       148  

Merchandise

    200       246  

Nutrien Financial

    66       57  

Nutrien Financial elimination 1

    (22     (25
      3,308       3,422  

 Potash sales by geography

   

Manufactured product

   

North America

    520       417  

Offshore 2

    407       660  
      927       1,077  

 Nitrogen sales by product line

   

Manufactured product

   

Ammonia

    244       416  

Urea and ESN®

    366       491  

Solutions, nitrates and sulfates

    319       371  

Other nitrogen and purchased products

    99       140  
      1,028       1,418  

 Phosphate sales by product line

   

Manufactured product

   

Fertilizer

    321       302  

Industrial and feed

    167       195  

Other phosphate and purchased products

    11       75  
      499       572  

1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

2 Relates to Canpotex Limited (“Canpotex”) (see Note 9) and includes provisional pricing adjustments for the three months ended March 31, 2024 of $12 million (2023 – $(147) million).

 

27


Unaudited  

 

Note 3 Other expenses (income)

 

    

Three Months Ended

March 31

 
 (millions of US dollars)        2024         2023   

 Integration and restructuring related costs

     -         5   

 Foreign exchange loss (gain), net of related derivatives

     43         (34)  

 Earnings of equity-accounted investees

     (51)        (37)  

 Bad debt expense

     13         9   

 Project feasibility costs

     15         13   

 Customer prepayment costs

     16         14   

 Loss on natural gas derivatives not designated as hedge ¹

     3         -   

 Loss on Blue Chip Swaps

     19         -   

 ARO/ERL expense for non-operating sites

     3         -   

 Gain on amendments to other post-retirement pension plans

     -         (80)  

 Other expenses

     35         35   
       96         (75)  

1  Relates to unrealized loss for the three months ended March 31, 2024 (2023 – $nil).

Argentina has certain currency controls in place that limit our ability to settle our foreign currency-denominated obligations or remit cash out of Argentina. A Blue Chip Swap is a financial mechanism in Argentina that effectively allows companies to transact in US dollars. In the first quarter of 2024, we incurred a loss on these transactions due to the significant divergence between the Blue Chip Swap market exchange rate and the official Argentinian Central Bank rate.

Note 4 Income taxes

A separate estimated average annual effective income tax rate was determined and applied individually to the interim period pre-tax earnings for each taxing jurisdiction.

 

    

Three Months Ended

March 31

 
 (millions of US dollars, except as otherwise noted)       2024         2023   

 Actual effective tax rate on earnings (%)

     30         23   

 Actual effective tax rate including discrete items (%)

     31         25   

 Discrete tax adjustments that impacted the tax rate

     3         18   

Note 5 Financial instruments

Natural Gas Derivatives

In 2024, we increased our use of natural gas derivatives to lock-in commodity prices. Our risk management strategies and accounting policies for derivatives that are designated and qualify as cash flow hedges are consistent with those disclosed in Note 10 and Note 30 of our annual consolidated financial statements, respectively. For derivatives that do not quality as cash flow hedges, any gains or losses are recorded in net earnings in the current period.

We assess whether our derivative hedging transactions are expected to be or were highly effective, both at the hedge’s inception and on an ongoing basis, in offsetting changes in fair values of hedged items.

 

Hedging Transaction  

   Measurement of Ineffectiveness         

Potential Sources of Ineffectiveness

New York Mercantile Exchange (“NYMEX”) natural gas hedges    Assessed on a prospective and retrospective basis using regression analyses   

Changes in:

 timing of forecast transactions

 volume delivered

 our credit risk or the credit risk of  a counterparty 

 

28


Unaudited  

 

    As at March 31, 2024  
 (millions of US dollars, except as otherwise noted)   Notional 1    

Maturities

(year)

   

Average

Contract Price 2

   

Fair Value of

Assets (Liabilities)

 

 Derivatives not designated as hedges

       

NYMEX call options

    43       2024       2.77       7  

 Derivatives designated as hedges

       

NYMEX swaps

    36       2024       2.64       (9

 1 In millions of Metric Million British Thermal Units (“MMBtu”).

 2 US dollars per MMBtu.

Note 6 Short-term debt

On March 7, 2024, we entered into an uncommitted $500 million accounts receivable repurchase facility (the “repurchase facility”), where we may sell certain receivables from customers to a financial institution and agree to repurchase those receivables at a future date. When we draw under this repurchase facility, the receivables from customers remain on our condensed consolidated balance sheet as we control and retain substantially all of the risks and rewards associated with the receivables. As at March 31, 2024, $111 million in receivables from customers were pledged to the repurchase facility and $100 million of borrowings were included in short-term debt with variable interest accruing based on a margin and the Secured Overnight Financing Rate.

Note 7 Capital management

In March 2024, we filed a base shelf prospectus in Canada and the US qualifying the issuance, subject to the approval of the Board of Directors, of common shares, debt securities and other securities during a period of 25 months from March 22, 2024.

Note 8 Seasonality

Seasonality in our business results from increased demand for products during planting season. Crop input sales are generally higher in the spring and fall application seasons. Crop input inventories are normally accumulated leading up to each application season. The results of this seasonality have a corresponding effect on receivables from customers and rebates receivables, inventories, prepaid expenses and other current assets, and trade payables. Our short-term debt also fluctuates during the year to meet working capital requirements. Our cash collections generally occur after the application season is complete, while customer prepayments made to us are typically concentrated in December and January and inventory prepayments paid to our suppliers are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.

Note 9 Related party transactions

We sell potash outside Canada and the US exclusively through Canpotex. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed upon prices. Our total revenue is recognized at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex.

 

As at (millions of US dollars)      March 31, 2024        December 31, 2023  

Receivables from Canpotex

     148        162  

Note 10 Accounting policies, estimates and judgments

IFRS 18, “Presentation and Disclosure in Financial Statements” (“IFRS 18”), which was issued on April 9, 2024, would supersede IAS 1, “Presentation of Financial Statements” and increase the comparability of financial statements by enhancing principles on aggregation and disaggregation. IFRS 18 will be effective January 1, 2027, and will also apply to comparative information. We are reviewing the standard to determine the potential impact.

 

29